Managing late-life bipolar disorder: An update

Aging Health

Volumn 7, Issue 4, 2011, Pages 557-571

  Chen, Peijun ^a   Korobkova, Irina ^b   Busby, Katherine ^b   Sajatovic, Martha ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

antipsychotic medications; bipolar disorder; computed tomography; deep brain stimulation; depression; elderly; electroconvulsive therapy; mania; mood stabilizers; psychotherapy; transcranial magnetic stimulation

Indexed keywords

ARIPIPRAZOLE; ASENAPINE; CARBAMAZEPINE; CLOZAPINE; ILOPERIDONE; LAMOTRIGINE; LITHIUM SALT; LURASIDONE; OLANZAPINE; OXCARBAZEPINE; PLACEBO; QUETIAPINE; RISPERIDONE; VALPROIC ACID; ZIPRASIDONE;

AGRANULOCYTOSIS; ALTERNATIVE MEDICINE; AMMONIA BLOOD LEVEL; ARTHRITIS; ATAXIA; BIPOLAR DISORDER; BRAIN DEPTH STIMULATION; CEREBELLUM DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; COMORBIDITY; DEMOGRAPHY; DEPRESSION; DIARRHEA; DISTRIBUTION VOLUME; DIZZINESS; DROWSINESS; DRUG CLEARANCE; DRUG DOSE TITRATION; DRUG ELIMINATION; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG METABOLISM; ELECTROCONVULSIVE THERAPY; EVIDENCE BASED MEDICINE; FAMILY; FUNCTIONAL STATUS; GASTROINTESTINAL SYMPTOM; GERIATRIC PATIENT; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN RELATION; HYPONATREMIA; INSOMNIA; KIDNEY DISEASE; LIVER TOXICITY; MANIA; MENTAL DISEASE; NAUSEA; ONSET AGE; ORTHOSTATIC HYPOTENSION; PANCREATITIS; PERIPHERAL EDEMA; PSYCHOSIS; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; REVIEW; SEDATION; SIDE EFFECT; SOCIETY; SOMNOLENCE; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; TRANSCRANIAL MAGNETIC STIMULATION; TREMOR; URINARY FREQUENCY; WEIGHT GAIN; XEROSTOMIA;

EID: 80051716189     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/ahe.11.49     Document Type: Review

References (138)

1. Kessler RC, Berglund P, Demler O et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication Arch. Gen. Psychiatry 62(6), 593-602 (2005).
2. Weissman MM, Bland RC, Canino GJ et al. Cross-national epidemiology of major depression and bipolar disorder JAMA 276(4), 293-299 (1996).
3. Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey. Arch. Gen. Psychiatry 51(1), 8-19 (1994).
4. Regier DA, Boyd JH, Burke JD Jr et al. One-month prevalence of mental disorders in the United States. Based on five epidemiologic catchment area sites. Arch. Gen. Psychiatry 45(11), 977-986 (1988).
5. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases J. Affect. Disord. 73(1-2), 123-131 (2003).
6. Akiskal HS, Bourgeois ML, Angst J et al. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J. Affect. Disord. 59(Suppl. 1), S5-S30 (2000).
7. Szadoczky E, Papp Z, Vitrai J et al. The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey J. Affect. Disord. 50(2-3), 153-162 (1998).
8. Chen P, Ahmed M, Sajatovic M. Bipolar disorder in later life. Aging Health 2(2), 333-347 (2006).
9. Weissman MM, Leaf PJ, Tischler GL et al. Affective disorders in five United States communities. Psychol. Med. 18(1), 141-153 (1988).
10. Unutzer J, Simon G, Pabiniak C et al. The treated prevalence of bipolar disorder in a large staff-model HMO. Psychiatr. Serv. 49(8), 1072-1078 (1998).
11. Hirschfeld RM, Calabrese JR, Weissman MM et al. Screening for bipolar disorder in the community J. Clin. Psychiatry 64(1), 53-59 (2003).
12. Almeida OP, Fenner S. Bipolar disorder: similarities and differences between patients with illness onset before and after 65 years of age. Int. Psychogeriatr. 14(3), 311-322 (2002).
13. Yassa R, Nair V, Nastase C et al. Prevalence of bipolar disorder in a psychogeriatric population. J. Affect. Disord. 14(3), 197-201 (1988).
14. Depp CA, Lindamer LA, Folsom DP et al. Differences in clinical features and mental health service use in bipolar disorder across the lifespan. Am. J. Geriatr. Psychiatry 13(4), 290-298 (2005).
15. Depp CA, Jeste DV. Bipolar disorder in older adults: a critical review. Bipolar Disord. 6(5), 343-367 (2004).
16. Morgan VA, Mitchell PB, Jablensky AV. The epidemiology of bipolar disorder: sociodemographic, disability and service utilization data from the Australian national study of low prevalence (psychotic) disorders. Bipolar Disord. 7(4), 326-337 (2005).
17. Meeks S. Bipolar disorder in the latter half of life: symptom presentation, global functioning and age of onset. J. Affect. Disord. 52(1-3), 161-167 (1999).
18. Sajatovic M, Blow FC, Ignacio RV et al. New-onset bipolar disorder in later life. Am. J. Geriatr. Psychiatry 13(4), 282-289 (2005).
19. Vasudev A, Thomas A. 'Bipolar disorder' in the elderly: what's in a name? Maturitas 66(3), 231-235 (2010).
20. Kessing LV. Diagnostic subtypes of bipolar disorder in older versus younger adults. Bipolar Disord. 8(1), 56-64 (2006).
21. Lehmann SW, Rabins PV. Factors related to hospitalization in elderly manic patients with early and late onset bipolar disorder. Int. J. Geriatr. Psychiatry 21(11), 1060-1064 (2006).
22. Goldstein BI, Herrmann N, Shulman KI. Comorbidity in bipolar disorder among the elderly: results from an epidemiological community sample. Am. J. Psychiatry 163(2), 319-321 (2006).
23. Beyer JL, Kuchibhatla M, Cassidy F et al. Stressful life events in older bipolar patients. Int. J. Geriatr. Psychiatry 23(12), 1271-1275 (2008).
24. Radanovic M, Nunes PV, Gattaz WF et al. Language impairment in euthymic, elderly patients with bipolar disorder but no dementia. Int. Psychogeriatr. 20(4), 687-696 (2008).
25. Gildengers AG, Mulsant BH, Begley A et al. The longitudinal course of cognition in older adults with bipolar disorder. Bipolar Disord. 11(7), 744-752 (2009).
26. Gunning-Dixon FM, Murphy CF, Alexopoulos GS et al. Executive dysfunction in elderly bipolar manic patients. Am. J. Geriatr. Psychiatry 16(6), 506-512 (2008).
27. Prakash O, Kumar CN, Shivakumar PT et al. Clinical presentation of mania compared with depression: data from a geriatric clinic in India. Int. Psychogeriatr. 21(4), 764-767 (2009).
28. Depp CA, Moore DJ, Sitzer D et al. Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects. J. Affect. Disord. 101(1-3), 201-209 (2007).
29. Schouws SN, Zoeteman JB, Comijs HC et al. Cognitive functioning in elderly patients with early onset bipolar disorder. Int. J. Geriatr. Psychiatry 22(9), 856-861 (2007).
30. Gildengers AG, Butters MA, Chisholm D et al. Cognitive functioning and instrumental activities of daily living in late-life bipolar disorder. Am. J. Geriatr. Psychiatry 15(2), 174-179 (2007).
31. Delaloye C, Moy G, Baudois S et al. Cognitive features in euthymic bipolar patients in old age. Bipolar Disord. 11(7), 735-743 (2009).
32. Tsai SY, Lee HC, Chen CC et al. Cognitive impairment in later life in patients with early-onset bipolar disorder. Bipolar Disord. 9(8), 868-875 (2007).
33. Tsai SY, Kuo CJ, Chung KH et al. Cognitive dysfunction and medical morbidity in elderly outpatients with bipolar disorder. Am. J. Geriatr. Psychiatry 17(12), 1004-1011 (2009).
34. Subramaniam H, Dennis MS, Byrne EJ. The role of vascular risk factors in late onset bipolar disorder. Int. J. Geriatr. Psychiatry 22(8), 733-737 (2007).
35. Krauthammer C, Klerman GL. Secondary mania: manic syndromes associated with antecedent physical illness or drugs. Arch. Gen. Psychiatry 35(11), 1333-1339 (1978).
36. Van Gerpen MW, Johnson JE, Winstead DK. Mania in the geriatric patient population: a review of the literature. Am. J. Geriatr. Psychiatry 7(3), 188-202 (1999).
37. Ganzini L, Millar SB, Walsh JR. Drug-induced mania in the elderly. Drugs Aging 3(5), 428-435 (1993).
38. Abouesh A, Stone C, Hobbs WR. Antimicrobial-induced mania (antibiomania): a review of spontaneous reports. J. Clin. Psychopharmacol. 22(1), 71-81 (2002).
39. Robinson RG. Mood disorders secondary to stroke. Semin. Clin. Neuropsychiatry 2(4), 244-251 (1997).
40. Nakimuli-Mpungu E, Musisi S, Kiwuwa Mpungu S et al. Early-onset versus late onset HIV-related secondary mania in Uganda. Psychosomatics 49(6), 530-534 (2008).
41. Owe-Larsson B, Sall L, Salamon E et al. HIV infection and psychiatric illness. Afr. J. Psychiatry (Johannesbg) 12(2), 115-128 (2009).
42. Sajatovic M. Treatment of bipolar disorder in older adults. Int. J. Geriatr. Psychiatry 17(9), 865-873 (2002).
43. Catterson ML, Preskorn SH, Martin RL. Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology. Psychiatr. Clin. N. Am. 20(1), 205-218 (1997).
44. Sunderland T. Neurotransmission in the aging central nervous system. In:Clinical geriatric Psychopharmacology . Salzman C (Ed.).Lippincott Williams & Wilkins, PA, USA, 63-86 (2005).
45. Bowden CL, Brugger AM, Swann AC et al. Efficacy of divalproex lithium and placebo in the treatment of mania. The depakote mania study group. JAMA 271(12), 918-924 (1994).
46. Bowden CL, Mosolov S, Hranov L et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial. Int. Clin. Psychopharmacol. 25(2), 60-67 (2010).
47. BALANCE Investigators and Collaborators; Geddes JR, Goodwin GM, Rendell J et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 375(9712), 385-395 (2010).
48. Kessing LV, Sondergard L, Kvist K et al. Suicide risk in patients treated with lithium. Arch. Gen. Psychiatry 62(8), 860-866 (2005).
49. Schaffer CB, Garvey MJ. Use of lithium in acutely manic elderly patients. Clin. Gerontol. 3, 58-60 (1984).
50. Shulman KI, Rochon P, Sykora K et al. Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ 326(7396), 960-961 (2003).
51. Blanco C, Laje G, Olfson M et al. Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am. J. Psychiatry 159(6), 1005-1010 (2002).
52. Young RC, Schulberg HC, Gildengers AG et al. Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BD. Bipolar Disord. 12(1), 56-67 (2010).
53. Forester BP, Streeter CC, Berlow YA et al. Brain lithium levels and effects on cognition and mood in geriatric bipolar disorder: a lithium-7 magnetic resonance spectroscopy study. Am. J. Geriatr. Psychiatry 17(1), 13-23 (2009).
54. Juurlink DN, Mamdani MM, Kopp A et al. Drug-induced lithium toxicity in the elderly: a population-based study. J. Am. Geriatr. Soc. 52(5), 794-798 (2004).
55. Shulman KI, Sykora K, Gill SS et al. New thyroxine treatment in older adults beginning lithium therapy: implications for clinical practice. Am. J. Geriatr. Psychiatry 13(4), 299-304 (2005).
56. Vestergaard P, Rejnmark L, Mosekilde L. Reduced relative risk of fractures among users of lithium. Calcif. Tissue Int. 77(1), 1-8 (2005).
57. Gildengers AG, Mulsant BH, Begley AE et al. A pilot study of standardized treatment in geriatric bipolar disorder. Am. J. Geriatr. Psychiatry 13(4), 319-323 (2005).
58. Allen MH, Hirschfeld RM, Wozniak PJ et al. Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania. Am. J. Psychiatry 163(2), 272-275 (2006).
59. Chen ST, Altshuler LL, Melnyk KA et al. Efficacy of lithium. Valproate in the treatment of mania in the elderly: a retrospective study. J. Clin. Psychiatry 60(3), 181-186 (1999).
60. Sandson NB, Marcucci C, Bourke DL et al. An interaction between aspirin and valproate: the relevance of plasma protein displacement drug-drug interactions. Am. J. Psychiatry 163(11), 1891-1896 (2006).
61. Bowden CL, Lawson DM, Cunningham M. The role of divalproex in the treatment of bipolar disorder. Psychiatry Ann. 32(12), 742-750 (2002).
62. Post RM, Uhde TW, Roy-Byrne PP et al. Correlates of antimanic response to carbamazepine. Psychiatry Res. 21(1), 71-83 (1987).
63. Evans DL, Byerly MJ, Greer RA. Secondary mania: diagnosis and treatment. J. Clin. Psychiatry 56(Suppl. 3), 31-37 (1995).
64. Battino D, Croci D, Rossini A et al. Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data. Epilepsia 44(7), 923-929 (2003).
65. Chen PJ. The efficacy and blood concentration monitoring of carbamazepine on mania. Zhonghua Shen Jing Jing Shen Ke Za Zhi 23(5), 261-265, 318 (1990).
66. Leppik IE. Issues in the treatment of epilepsy. Epilepsia. 42 (Suppl. 4), 1-6 (2001).
67. Fuller M, Sajatovic M. Drug Information Handbook for Psychiatry Lexi-Comp, Inc., Cleveland, OH, USA (2009).
68. Calabrese JR, Bowden CL, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J. Clin. Psychiatry 64(9), 1013-1024 (2003).
69. Bowden CL, Calabrese JR, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Gen. Psychiatry 60(4), 392-400 (2003).
70. Sajatovic M, Gyulai L, Calabrese JR et al. Maintenance treatment outcomes in older patients with bipolar I disorder. Am. J. Geriatr. Psychiatry 13(4), 305-311 (2005).
71. Sajatovic M, Gildengers A, Al Jurdi RK et al. Multi-site, open-label, prospective trial of lamotrigine for geriatric bipolar depression (2010).Presented at: The American Psychiatric Association Conference. New Orleans, LA, USA, 14-16 May 2010.
72. Willmore LJ, Messenheimer JA. Adult experience with lamotrigine. J. Child Neurol. 12(Suppl. 1), S16-S18 (1997).
73. Messenheimer JA. Lamotrigine. Epilepsia. 36(Suppl. 3), S87-S94 (1995).
74. Beyer JL, Siegal A, Kennedy JS. Olanzapine, divalproex and placebo treatment, non-head to head comparisons of older adults acute mania. Presented at: 10th Congress of the International Psychogeriatric Association. Nice, France, 9-14 September 2001.
75. Sajatovic M, Coconcea N, Ignacio RV et al. Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial. J. Clin. Psychiatry 69(1), 41-46 (2008).
76. Sajatovic M. Quetiapine for the treatment of depressive episodes in adults aged 55 to 65 years with bipolar disorder. Presented at: American Association of Geriatric Psychiatry (AAGP) Annual Meeting. New Orleans, LA, USA, 1-4 March 2007.
77. Madhusoodanan S, Brenner R, Araujo L et al. Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. J. Clin. Psychiatry 56(11), 514-518 (1995).
78. Madhusoodanan S, Suresh P, Brenner R et al. Experience with the atypical antipsychotics-risperidone and olanzapine in the elderly. Ann. Clin. Psychiatry 11(3), 113-118 (1999).
79. Shulman RW, Singh A, Shulman KI. Treatment of elderly institutionalized bipolar patients with clozapine. Psychopharmacol. Bull. 33(1), 113-118 (1997).
80. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27(2), 596-601 (2004).
81. Wang PS, Schneeweiss S, Avorn J et al. Risk of death in elderly users of conventional atypical antipsychotic medications. N. Engl. J. Med. 353(22), 2335-2341 (2005).
82. Kales HC, Valenstein M, Kim HM et al. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am. J. Psychiatry 164(10), 1568-1576 (2007).
83. Aziz R, Lorberg B, Tampi RR. Treatments for late-life bipolar disorder. Am. J. Geriatr. Pharmacother. 4(4), 347-364 (2006).
84. Crystal S, Olfson M, Huang C et al. Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Aff. (Millwood) 28(5), W770-W781 (2009).
85. Sachs GS, Nierenberg AA, Calabrese JR et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N. Engl J. Med. 356(17), 1711-1722 (2007).
86. Goldberg JF, Perlis RH, Ghaemi SN et al. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am. J. Psychiatry 164(9), 1348-1355 (2007).
87. Schaffer A, Mamdani M, Levitt A et al. Effect of antidepressant use on admissions to hospital among elderly bipolar patients. Int. J. Geriatr. Psychiatry 21(3), 275-280 (2006).
88. Aizenberg D, Olmer A, Barak Y. Suicide attempts amongst elderly bipolar patients. J. Affect. Disord. 91(1), 91-94 (2006).
89. Leverich GS, Altshuler LL, Frye MA et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am. J. Psychiatry 163(2), 232-239 (2006).
90. Duboky SL. Treatment of bipolar depression. Psychiatr. Clin. North Am. 28(2), 349-370 (2005).
91. Weiner RD, Coffey CE, Fochtmann LJ et al. The Practice of Electroconvulsive Therapy. Recommendations for the Treatment, Training, and Privileging: A Task Force Report of the American Psychiatric Association Washington. American Psychiatric Association, Washington, DC, USA (2001).
92. Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am. J. Psychiatry 151(2), 169-176 (1994).
93. Ciapparelli A, Dell'Osso L, Tundo A et al. Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. J. Clin. Psychiatry 62(7), 552-555 (2001).
94. Devanand DP, Polanco P, Cruz R et al. The efficacy of ECT in mixed affective states. J. ECT 16(1), 32-37 (2000).
95. Gruber NP, Dilsaver SC, Shoaib AM et al. ECT in mixed affective states: a case series. J. ECT 16(2), 183-188 (2000).
96. Medda P, Perugi G, Zanello S et al. Response to ECT in bipolar I, bipolar II and unipolar depression. J. Affect. Disord. 118(1-3), 55-59 (2009).
97. Daly JJ, Prudic J, Devanand DP et al. ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disord. 3(2), 95-104 (2001).
98. Grunhaus L, Schreiber S, Dolberg OT et al. Response to ECT in major depression: are there differences between unipolar and bipolar depression? Bipolar Disord. 4(Suppl. 1), 91-93 (2002).
99. Bailine S, Fink M, Knapp R et al. Electroconvulsive therapy is equally effective in unipolar and bipolar depression. Acta Psychiatr. Scand. 121(6), 431-436 (2010).
100. Hallam KT, Smith DI, Berk M. Differences between subjective and objective assessments of the utility of electroconvulsive therapy in patients with bipolar and unipolar depression. J. Affect. Disord. 112(1-3), 212-218 (2009).
101. Tew JD Jr, Mulsant BH, Haskett RF et al. Acute efficacy of ECT in the treatment of major depression in the old-old. Am. J. Psychiatry 156(12), 1865-1870 (1999).
102. O'Connor MK, Knapp R, Husain M et al. The influence of age on the response of major depression to electroconvulsive therapy: A C.O.R.E. Report. Am. J. Geriatric. Psychiatry 9, 382-390 (2001).
103. Dombroki AY, Mulsant BH, Haskett RF et al. Predictors of remission after electroconvulsive therapy in unipolar major depression. J. Clin. Psychiatry 66, 1043-1049 (2005).
104. Damm J, Eser D, Schule C et al. Influence of age on effectiveness and tolerability of electroconvulsive therapy J. ECT 26(4), 282-288 (2010).
105. Manly DT, Oakley SP Jr, Bloch RM. Electroconvulsive therapy in old-old patients. Am. J. Geriatr. Psychiatry 8(3), 232-236 (2000).
106. Sackeim HA, Prudic J, Fuller R et al. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology 32(1), 244-254 (2007).
107. Kujala I, Rosenvinge B, Bekkelund SI. Clinical outcome and adverse effects of electroconvulsive therapy in elderly psychiatric patients. J. Geriatr. Psychiatry Neurol. 15(2), 73-76 (2002).
108. Russell JC, Rasmussen KG, O'Connor MK et al. Long-term maintenance ECT: a retrospective review of efficacy and cognitive outcome. J. ECT 19(1), 4-9 (2003).
109. Vaidya NA, Mahableshwarkar AR, Shahid R. Continuation and maintenance ECT in treatment-resistant bipolar disorder. J. ECT 19(1), 10-16 (2003).
110. Hallett M. Transcranial magnetic stimulation and the human brain. Nature 406(6792), 147-150 (2000).
111. Hoogendam JM, Ramakers GM, Di Lazzaro V. Physiology of repetitive transcranial magnetic stimulation of the human brain. Brain Stimul. 3(2), 95-118 (2010).
112. Milev R, Abraham G, Hasey G et al. Repetitive transcranial magnetic stimulation for treatment of medication-resistant depression in older adults: a case series. J. ECT 25(1), 44-49 (2009).
113. Abraham G, Milev R, Lazowski L et al. Repetitive transcranial magnetic stimulation for treatment of elderly patients with depression-an open label trial. Neuropsychiatr. Dis. Treat. 3(6), 919-924 (2007).
114. Mosimann UP, Schmitt W, Greenberg BD et al. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients. Psychiatry Res. 126(2), 123-133 (2004).
115. Manes F, Jorge R, Morcuende M et al. A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly. Int. Psychogeriatr. 13(2), 225-231 (2001).
116. Nahas Z, Li X, Kozel FA et al. Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study. Depress. Anxiety 19(4), 249-256 (2004).
117. Cohen RB, Brunoni AR, Boggio PS et al. Clinical predictors associated with duration of repetitive transcranial magnetic stimulation treatment for remission in bipolar depression: a naturalistic study. J. Nerv. Ment. Dis. 198(9), 679-681 (2010).
118. Loo CK, Mitchell PB. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. J. Affect. Disord. 88(3), 255-267 (2005).
119. Rachid F, Bertschy G. Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of depression: a critical appraisal of the last 10 years. Neurophysiol. Clin. 36(3), 157-183 (2006).
120. Xia G, Gajwani P, Muzina DJ et al. Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation. Int. J. Neuropsychopharmacol. 11(1), 119-130 (2008).
121. Moser DJ, Jorge RE, Manes F et al. Improved executive functioning following repetitive transcranial magnetic stimulation. Neurology 58(8), 1288-1290 (2002).
122. Huang CC, Wei IH, Chou YH et al. Effect of age, gender, menopausal status, and ovarian hormonal level on rTMS in treatment-resistant depression. Psychoneuroendocrinology 33(6), 821-831 (2008).
123. Hamani C, Nobrega JN. Deep brain stimulation in clinical trials and animal models of depression. Eur. J. Neurosci. 32(7), 1109-1117 (2010).
124. Lipsman N, McIntyre RS, Giacobbe P et al. Neurosurgical treatment of bipolar depression: defining treatment resistance and identifying surgical targets. Bipolar Disord. 12(7), 691-701 (2010).
125. Neiberg RH, Aickin M, Grzywacz JG et al. Occurrence and co-occurrence of types of complementary and alternative medicine use by age, gender, ethnicity, and education among adults in the United States: the 2002 national health interview survey (NHIS).J. Altern. Complement Med. 17(4), 363-370 (2011).
126. Keaton D, Lamkin N, Cassidy KA et al. Utilization of herbal and nutritional compounds among older adults with bipolar disorder and with major depression. Int. J. Geriatr. Psychiatry 24(10), 1087-1093 (2009).
127. Miklowitz DJ, Otto MW, Frank E et al. Psychosocial treatments for bipolar depression: a 1-year randomized trial from the systematic treatment enhancement program. Arch. Gen. Psychiatry 64(4), 419-426 (2007).
128. Miklowitz DJ, Otto MW, Wisniewski SR et al. Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder. Psychiatr. Serv. 57(7), 959-965 (2006).
129. Frank E, Soreca I, Swartz HA et al. The role of interpersonal and social rhythm therapy in improving occupational functioning in patients with bipolar I disorder. Am. J. Psychiatry 165(12), 1559-1565 (2008).
130. Clarkin JF, Carpenter D, Hull J et al. Effects of psychoeducational intervention for married patients with bipolar disorder and their spouses. Psychiatr. Serv. 49(4), 531-533 (1998).
131. Miklowitz DJ. Adjunctive psychotherapy for bipolar disorder: state of the evidence. Am. J. Psychiatry 165(11), 1408-1419 (2008).
132. Antognini F: Psychotherapy with Depressed Older Adults. In:Depression in Later Life: A Multidisciplinary Psychiatric Approach . Ellison JM, Verma S (Eds.), Marcel Dekker, New York, NY, USA, 257-296 (2003).
133. Simon NM, Smoller JW, McNamara KL et al. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol. Psychiatry 60(5), 432-435 (2006).
134. Yatham LN, Kapczinski F, Andreazza AC et al. Accelerated age-related decrease in brain-derived neurotrophic factor levels in bipolar disorder. Int. J. Neuropsychopharmacol. 12(1), 137-139 (2009).
135. Berk M. Neuroprogression: pathways to progressive brain changes in bipolar disorder. Int. J. Neuropsychopharmacol. 12(4), 441-445 (2009).
136. Kapczinski F, Vieta E, Andreazza AC et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci. Biobehav. Rev. 32(4), 675-692 (2008).
137. Kessing LV, Andersen PK. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J. Neurol. Neurosurg. Psychiatry 75(12), 1662-1666 (2004).
138. Sajatovic M, Blow FC, Kales HC et al. Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder. Int. J. Geriatr. Psychiatry 22(10), 992-998 (2007).